Sanofi said this morning that its pipeline includes 12 potential blockbuster drugs that could generate more than €10 billion ($11 billion) in annual sales by the end of the decade, a sharp ...

Head lice affect more than 100 million people worldwide annually. Permethrin (1% formulation) is efficacious but resistance is emerging. Malathion (0.5% formulation) is an alternative, but ...

"A safe and effective dengue virus vaccine is clearly the long-term solution, but more immediate strategies are urgently needed to combat the current dengue problem." There is reason to be ...

Sanofi India Limited (Previously known as Aventis Pharma Limited) was incorporated in May 1956. The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11 2012. The ...

Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 14,605.21 Crore) operating in Pharmaceuticals sector. Sanofi India Ltd. key Products/Revenue Segments ...